GDP-validated pharma warehouse — UAE
Regional distributor for vaccines, biologics and oncology needed a GDP-compliant facility with redundant cooling, controlled access and full audit trail.
Challenge
- Zero-downtime requirement during summer (45 °C+ ambient).
- Validation timeline tied to Ministry of Health licensing.
- Mixed +2/+8 °C and −20 °C zones in the same building envelope.
ColdMatch solution
- Dual-redundant chillers with N+1 architecture and 24h backup.
- Calibrated mapping, 21 CFR Part 11 monitoring, validated SOPs.
- ColdMatch coordinated WHO/GDP commissioning with the EPC.
How this project was delivered — planning to commissioning
Design-and-build with an independent qualification consultant. Total programme: 22 months, concept to licensed operation.
- 1
Planning & feasibility
Months 1–5- Product portfolio mapped to +2/+8 °C, −20 °C and controlled ambient zones.
- Redundancy strategy defined for 45 °C+ summer ambient, including N+1 chillers and backup power.
- User Requirement Specification (URS) written before supplier engagement.
Milestone: URS and validation master plan approved.
- 2
Permitting & approvals
Months 5–9- Ministry of Health warehouse licensing pathway agreed and documentation scheduled.
- Civil defence, fire and building approvals for the mixed-temperature envelope.
- Controlled-substance storage and access-control requirements built into the design.
Milestone: Licensing pathway locked with regulator milestones in the project plan.
- 3
Procurement & build-out
Months 9–17- Dual-redundant chiller plant, BMS and 24-hour backup installed.
- Segregated +2/+8 °C and −20 °C rooms constructed inside one building envelope.
- 21 CFR Part 11 compliant monitoring system installed with calibrated sensors.
Milestone: Construction complete, systems energised, IQ documentation issued.
- 4
Testing & validation
Months 17–21- IQ / OQ / PQ executed room by room with an independent qualification team.
- Empty and loaded temperature mapping, plus power-failure and door-open excursion studies.
- SOPs, deviation handling and training records completed for GDP inspection.
Milestone: Zero mapping deviations; validation dossier accepted by the regulator.
- 5
Commissioning & handover
Months 21–22- WHO/GDP commissioning walkthrough with the EPC and quality team.
- Alarm escalation, on-call response and calibration schedule activated.
- First licensed product received under full audit trail.
Milestone: Operating licence granted and facility released for distribution.
This project sits under the Build a Pharmaceutical Cold Chain objective. Start from the objective hub to scope capacity, permitting and budget before engaging suppliers.
Project brief → RFQ package → supplier outreach → outcome
Every ColdMatch project follows the same managed sequence. Nothing reaches a supplier before the ColdMatch project team has reviewed the brief and confirmed the project scope, budget and timeline.
1. Project brief
- Submitted via
- Pharma cold-chain RFQ — GDP-validated distribution
- Review
- Reviewed manually by the ColdMatch project team with a GDP validation specialist
Clarified before outreach
- Licence milestones with the Ministry of Health and the validation evidence required.
- Split between +2/+8 °C and −20 °C zones and expected SKU growth over five years.
- Redundancy expectation during 45 °C+ summer ambient conditions.
Qualification checks
- Project value well above threshold (indicated US$ 7–9M).
- Regulatory deadline confirmed in writing, fixing the programme.
- Buyer confirmed a qualified person accountable for validation sign-off.
2. RFQ package issued
Two-envelope RFQ (technical and commercial submitted separately)
Documents in the pack
- URS covering mapping, alarms, access control and 21 CFR Part 11 data integrity.
- Zone schedule for +2/+8 °C and −20 °C areas within one envelope.
- N+1 redundancy and backup-power requirement with hold-time targets.
- Validation deliverables list: IQ/OQ/PQ, mapping protocol, SOP handover.
Mandatory supplier returns
- Redundancy architecture with single-point-of-failure analysis.
- Temperature hold-time under total power loss, with calculation basis.
- Validation resourcing plan and named GDP consultant.
- Commissioning schedule aligned to the licensing date.
3. Managed supplier outreach
- Approached
- 7 EPCs and 2 validation houses screened across the GCC and Europe
- Shortlisted
- 3 EPCs, each paired with an independent validation partner
- Round 1 — GDP evidence
Only suppliers with completed GDP-licensed facilities in high-ambient climates progressed.
- Round 2 — technical tender
Redundancy and hold-time claims stress-tested against the URS in a technical clarification session.
- Round 3 — programme lock
Commissioning and validation dates contractually tied to the licence milestone.
Evaluation weighting
- Regulatory & validation track record
- 35%
- Redundancy and hold-time performance
- 30%
- Programme certainty
- 20%
- Price (normalised scope)
- 15%
4. Commercial outcome
Dual-redundant chiller architecture with an EPC + validation-house pairing
Delivered results
- 99.997% uptime since handover.
- Zero mapping deviations at licensing.
- Licence achieved in 11 months on a US$ 8.6M project.
Run the pharma readiness check, then submit your GDP brief for manual review.
Project records are anonymised at the buyer's request and presented as planning-grade benchmarks. Costs, timelines and performance figures are indicative and are not engineering designs or quotations.
Supplier and manufacturer information is provided for research only; it is not a directory for direct contact. There is no direct buyer-to-supplier connection: every RFQ comes to the ColdMatch team, which validates it, contacts suitable suppliers on the buyer's behalf and presents organized responses through ColdMatch.